v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Income Statement [Abstract]        
Revenue $ 190,193 $ 158,223 $ 546,531 $ 451,406
Cost of revenue 69,783 65,894 201,989 201,163
Gross profit 120,410 92,329 344,542 250,243
Operating expenses:        
Research and development 42,766 41,421 126,809 121,071
Sales and marketing 56,631 49,998 168,480 150,411
General and administrative 31,272 29,698 97,840 82,256
Impairment expense 1,013 0 1,013 415
Total operating expenses 131,682 121,117 394,142 354,153
Loss from operations (11,272) (28,788) (49,600) (103,910)
Interest income 2,822 3,080 8,591 9,139
Interest expense (3,315) (3,161) (9,969) (9,498)
Other income (expense), net 43 (55) (737) (96)
Loss before income taxes (11,722) (28,924) (51,715) (104,365)
Income tax (benefit) expense (467) 559 (4,345) 1,807
Net loss $ (11,255) $ (29,483) $ (47,370) $ (106,172)
Net loss per share attributable to common stockholders, basic (in dollars per share) $ (0.07) $ (0.20) $ (0.30) $ (0.73)
Net loss per share attributable to common stockholders, diluted (in dollars per share) $ (0.07) $ (0.20) $ (0.30) $ (0.73)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares) 159,989 148,129 157,078 145,749
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares) 159,989 148,129 157,078 145,749